08/25/2025
6:39 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:53 PM | Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:54 PM | Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:58 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:58 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
8:30 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
5:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
4:01 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
4:02 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for FOLD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amicus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
4:03 PM | Amicus Therapeutics (Filer)
| Form ARS | |
04/23/2025
7:14 PM | Amicus Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
03/18/2025
4:56 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
6:27 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
7:00 PM | Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
4:14 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:17 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:19 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:22 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:00 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
9:25 AM | Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
6:02 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:03 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:04 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:06 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:06 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:12 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:43 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:00 PM | Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
10:37 AM | Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:31 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
4:49 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:03 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
5:23 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:49 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad) While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit.
One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet. See the full details on this “backdoor” Musk bet here |
10/17/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
12:24 PM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
10/04/2024
3:05 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:35 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
